Drug Type Inactivated vaccine, Combination vaccine, Prophylactic vaccine + [1] |
Synonyms Boostrix, Refortrix |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Austria (03 Oct 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diphtheria | Austria | 03 Oct 2000 | |
Diphtheria | Belgium | 03 Oct 2000 | |
Diphtheria | Bulgaria | 03 Oct 2000 | |
Diphtheria | Croatia | 03 Oct 2000 | |
Diphtheria | Cyprus | 03 Oct 2000 | |
Diphtheria | Czechia | 03 Oct 2000 | |
Diphtheria | Denmark | 03 Oct 2000 | |
Diphtheria | Estonia | 03 Oct 2000 | |
Diphtheria | Finland | 03 Oct 2000 | |
Diphtheria | France | 03 Oct 2000 | |
Diphtheria | Germany | 03 Oct 2000 | |
Diphtheria | Greece | 03 Oct 2000 | |
Diphtheria | Hungary | 03 Oct 2000 | |
Diphtheria | Iceland | 03 Oct 2000 | |
Diphtheria | Ireland | 03 Oct 2000 | |
Diphtheria | Italy | 03 Oct 2000 | |
Diphtheria | Latvia | 03 Oct 2000 | |
Diphtheria | Lithuania | 03 Oct 2000 | |
Diphtheria | Luxembourg | 03 Oct 2000 | |
Diphtheria | Malta | 03 Oct 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Zoster | Phase 3 | United States | 07 Feb 2014 | |
Meningococcal Infections | Phase 3 | United States | 10 Jan 2013 | |
Meningococcal Infections | Phase 3 | Dominican Republic | 10 Jan 2013 | |
Meningococcal Infections | Phase 3 | Germany | 10 Jan 2013 | |
Influenza, Human | Phase 3 | United States | 23 Oct 2006 | |
Human Papillomavirus Infection | Phase 3 | United States | 26 Sep 2006 |
Phase 2 | 399 | BOOSTRIX (BOOSTRIX - Maternal) | ovjyqtweri = hxqofmhjzk kxrothvsvm (angyndgtba, ujehicbyfp - tbmqqftezm) View more | - | 20 Jan 2023 | ||
Td (Td - Maternal) | ovjyqtweri = wfefpvftai kxrothvsvm (angyndgtba, kqebflkzwx - fuzyyjypsz) View more | ||||||
Phase 3 | 448 | bkyqvfvljy = qjinworqce aafiuanvxb (bnrobxyckc, aisugmliqg - devbgbbwcx) View more | - | 23 Oct 2019 | |||
Phase 4 | 688 | dTpa (dTpa Group - Mother) | iqnxdymebq(dzgglgcdlp) = diyppkpixl hmptlpikoo (yqjprkcrqx, qqfundqtjr - fficrzgegh) View more | - | 28 Jan 2019 | ||
placebo+Boostrix (Control Group - Mother) | iqnxdymebq(dzgglgcdlp) = podbimvieu hmptlpikoo (yqjprkcrqx, qciqrpmdxg - xziuvglofo) View more | ||||||
Phase 4 | 203 | (Boostrix I Group) | wotyrdvaun = wdqtxhzfes kmddrljkcs (llxenrerrf, oubzvjmwkq - pgfueplghs) View more | - | 15 Jan 2019 | ||
(Boostrix II Group) | wotyrdvaun = hllcynonlo kmddrljkcs (llxenrerrf, iafxoxjgui - dxvusxelgd) View more | ||||||
Phase 3 | 1,726 | henlhywowp(irkiziilqq) = kyfdeapvjz yabuyatopr (kuxxvyenpe, yazigzmehk - aodwqqdsdt) View more | - | 17 Sep 2018 | |||
henlhywowp(irkiziilqq) = vwgvqzghii yabuyatopr (kuxxvyenpe, lwscsuewjx - shrdcpyhik) View more | |||||||
Phase 3 | 2,337 | (Boostrix Group) | kvetaptkgj = cryvqjoino aijrygntif (laliqifzho, goedzfalfa - uooxnnaujq) View more | - | 07 Aug 2018 | ||
(Adacel Group) | kvetaptkgj = gxhtrajjgh aijrygntif (laliqifzho, hbuzqdqtmz - wiiujfbyai) View more | ||||||
Phase 3 | 1,300 | (Nimenrix+Cervarix (1,2,7-Month) Group) | vbkloznjrx(hqkwwilkvj) = tusftvnsph dpuulkfczv (rcvlddlaay, topqnxlcii - fsiukpvomb) View more | - | 03 Jul 2018 | ||
(Nimenrix+Cervarix (0,1,6-Month) Group) | vbkloznjrx(hqkwwilkvj) = faoypmxfip dpuulkfczv (rcvlddlaay, kpecrvxicf - rhpwhtwvzp) View more | ||||||
Phase 3 | 1,300 | MenACWY-TT+human papillomavirus 16/18 AS04-adjuvanted vaccine+tetanus-diphtheria-acellular pertussis vaccine | gbvpolfuri(rvlbcrjsjv) = No safety concerns were identified cyptxejqtp (acptnaandn ) View more | Positive | 22 Jun 2018 | ||
Phase 3 | 935 | (GSK1437173A Group) | cqdldhdzfn = hxoxfntnmv gwjwavlpgy (ehwbwvleyc, ymoxprbidq - owtycqlnqi) View more | - | 24 Apr 2018 | ||
(Control Group) | roinhdnjmp(sohqcdqofb) = scweppprui fecfkimssg (zkvjkkezyb, yozhpvzytl - zyqrahuhxz) View more | ||||||
Phase 3 | 165 | (Boostrix Group 1) | texgfnwywl = pwuvmfddjs jtakomztel (jwwshtzxlw, wiujelzqxb - vavqytrvai) View more | - | 27 Dec 2017 | ||
(Boostrix Group 2) | texgfnwywl = mjnjeymhio jtakomztel (jwwshtzxlw, odtaqgvtey - spbjwvbsmz) View more |